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Abstract
Background: Surface-Enhanced Laser Desorption/Ionization – Time Of Flight (SELDI-TOF) has
been proposed as new approach for blood biomarker discovery. However, results obtained so far
have been often disappointing as this technique still has difficulties to detect low-abundant plasma
and serum proteins.
Results: We used a serum depletion scheme using chicken antibodies against various abundant
proteins to realized a pre-fractionation of serum prior to SELDI-TOF profiling. Depletion of major
serum proteins by immunocapture was confirmed by 1D and 2D gel electrophoresis. SELDI-TOF
analysis of bound and unbound (depleted) serum fractions revealed that this approach allows the
detection of new low abundant protein peaks with satisfactory reproducibility.
Conclusion: The combination of immunocapture and SELDI-TOF analysis opens new avenues into
proteomic profiling for the discovery of blood biomarkers.
Background
Human serum and plasma have an important clinical
value for identification and detection of biomarkers.
However, the analysis of these biological fluids is analyti-
cally challenging due to the high dynamic concentration
range (over 10 orders of magnitude) of constituent pro-
tein/peptide species [1]. In addition, the few most abun-
dant blood proteins constitute 95% of the bulk mass of
proteins but they represent less than 0.1% of the total
number of proteins. These high abundant proteins, and in
particular albumin, produce large signals in most pro-
teomics approaches and they mask or interfere with the
detection of the other low amount protein components.
This situation explains why the discovery of new proteins
or peptides biomarkers in blood is challenging. To mini-
mize these problems, proteomics techniques are con-
stantly improving to provide a wider range and an
optimized detection of low concentration candidates
[2,3]. Many methods rely on a multidimensional separa-
tion scheme combining for example multidimensional
chromatography or electrophoresis and mass spectrome-
try (MS) [4,5]. This is the case of the Surface-Enhanced
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Laser Desorption/Ionization – Time Of Flight (SELDI-
TOF) method [6,7] that relies on MS to detect proteins
and peptides initially selected by binding to various chro-
matographic surfaces (anionic, cationic, IMAC, hydro-
phobic). SELDI-TOF therefore focuses on a particular
subset of the proteome for each of the capture conditions.
However, results obtained so far with this technology
have been often disappointing and controversial [8,9]. In
fact this technology still has difficulties to detect low-
abundant plasma and serum proteins and could benefit
from additional pre-fractionation methods of blood (for
review see Issaq et al, [10]). Thus, liquid chromatography
[11], binding to solid-phase libraries [12,13] or enrich-
ment of low molecular weight proteins [14] have been
shown to improve SELDI-TOF analysis with however
some drawback in terms of practicability, reproducibility,
cost or difficulties to adapt to a high throughput
approach.
Results and discussion
Here, we evaluated the interest of the removal of major
serum protein for SELDI-TOF analysis. Removal of major
serum proteins can be achieved by immobilized dye [15]
or immunoaffinity [16,17] and it is a well known
approach to improved detection of minor blood proteins
in techniques such as two dimensional (2D) electro-
phoresis [17]. We used the IgY12 microbeads (Proteom-
Lab IgY12, Beckman) on serum samples as recommended
by the manufacturer. Briefly, 10 μL of samples were
diluted in TBS, added to IgY-microbead spin column and
incubated 15 min. The unbound fractions were collected
following the centrifugation of the columns. The columns
were then rinsed extensively before the elution using a
stripping buffer (0.1 M Glycine, pH 2.5) of the bound
fractions that were subsequently equilibrated for their pH.
The collected fractions were concentrated down to 40 μl
on PES ultrafiltration columns with a 10 kDa cut off for
hydragel separation and 2D electrophoresis and with a 3
kDa cut off for SELDI-TOF analysis. IgY12 columns are
designed to retain by immunocapture 90% to 99.5% of
the following 12 serum proteins: Albumin, Transferrin,
IgG, Haptoglobin, α1-antitrypsin, a2-macroglobulin, IgA,
IgM, Orosomucoid, ApoA-I, ApoA-II and Fibrinogen [18].
Protein quantification of the bound and unbound frac-
tions confirmed that, as expected, 84.3% (sd 2.3%) of the
total protein content was retained on the column [17].
This implies that the proteins remaining after depletion
have been arithmetically purified by a factor close to 6.4.
While 1 μL of undepleted serum was analysed on each
SELDI-TOF spot, the immunodepletion was performed
on 10 μL of serum and 1/3 of the resulting depleted frac-
tion was analysed, resulting therefore in a 3.3 fold
increase in the serum equivalent amount analysed. How-
ever, as the depleted fraction after PES concentration had
a volume close to 40 μL, the concentration of protein
remaining in this fraction is finally divided by 4. We con-
firmed the quality of the immunocapture by electrophore-
sis on agarose (Hydragel, Sebia) as illustrated in the Figure
1a. The unbound protein profile obtained, was dramati-
cally modified when compared that of the initial and the
bound fractions, which were alike. The different protein
fractions were also analyzed using 2D electrophoresis
(Figure 1, b–d) using pH 4–7 IPG strips (Amersham) for
the first dimension and 4–12% NuPAGE gels (Invitrogen)
for the second. Gels were stained with a modified silver
nitrate procedure as in Shevchenko et al [19]. The spot/
protein pattern was mainly modified in the unbound frac-
tion and we could confirm results obtained by Huang et
al [18] who concluded that immunocapture increases the
sensitivity of 2D electrophoresis for the detection of low
abundant proteins.
Initial, bound and unbound serum fractions were then
denatured using a Urea/CHAPS buffer and analysed by
SELDI-TOF using CM10 (weak cation exchange) Protein-
Chip arrays at pH4. To assess the repeatability and repro-
ducibility of the method, the same serum sample was
analysed 8 times the same day, and for four consecutive
days, respectively. The coefficients of variation (CV) were
calculated for the different protein peaks detected on the
spectra, as recommended by the Ciphergen company
(Table 1). The general repeatability of the SELDI-TOF
analysis was in our hand close to 15% which is satisfac-
tory for a manual technique. The reproducibility was
lower, with a CV close to 22%, as expected from the addi-
tional bias linked to experiments realized on different
days. When the immunocapture was realized beforehand,
we observed repeatability and reproducibility with CV of
16.7% and 25.3% respectively (Table 1). These values
were very close to those obtained without fractionation
confirming that this depletion technique was very robust
and did not significant increase variability.
As illustrated Table 2 and Figure 2 for m/z ratio ranging
from 3,000 to 15,000, few peaks were present only in the
bound fraction (Figure 2b, stars), while the unbound frac-
tion revealed many new peaks (Figure 2c, stars). This com-
parison of the profiles obtained before and after
immunocapture was performed with the Ciphergen
Biomarker Wizard software that aligns spectra and identi-
fies differential peaks. However, because of the low mass
accuracy of the PBS-II spectrometer when a new peak is
close in m/z from a pre-existing peak, we cannot be
entirely confident that this peak is new. Nevertheless, the
profiles were clearly different in many sections and they
were new detected peaks where, before immunodeple-
tion, only the background was detected (Figure 2c and
2g). Pearson factor was also used to asses the general
reproducibly of the different profiles and it was above 0.9
(Table 2) confirming the Table 1 results. HierarchicalProteome Science 2006, 4:20 http://www.proteomesci.com/content/4/1/20
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Cluster analysis (Using Hierarchical Clustering Explorer
software, HCE v3 [20]) of the SELDI-TOF data (Figure
2d), revealed the presence of two main clusters, one being
composed by serum and bound protein profiles and the
second by unbound profiles. This clearly illustrates the
fact that some new protein peaks were retained by the col-
umn (Figure 2d, stars), while many were detected only in
the unbound fraction (Figure 2d, triangles).
Using CM10 ProteinChip, purified recombinant IL-8
could be detected as a 8,600 m/z peak (Figure 2e). We
used this molecule spiked into the serum to illustrate the
potency of the immunodepletion approach for the detec-
tion of low abundant proteins. Using a serum supple-
mented with 0.1 ng/μl of this recombinant IL-8 (11,4
pM), no obvious peak aligned with that of IL-8 was detect-
able when this it was directly analyzed by SELDI-TOF (Fig-
ure 2f). However, after Y12 immunodepletion and SELDI-
TOF, a peak likely corresponding to IL-8, which was
absent in non spiked serum (not shown), was readily
detected in the unbound fraction (Figure 2g, star).
Fractionation of serum protein by IgY12 spin columns followed by 1D and 2D electrophoresis Figure 1
Fractionation of serum protein by IgY12 spin columns followed by 1D and 2D electrophoresis. Panel a: 1D elec-
trophoresis is performed using Hydragel separation kit (Sebia) which allows the detection of major serum proteins including Ig 
light chains, albumin, transferin, IgG, IgA, Haptoglobin, IgM and alpha-2-macroglobulin. Lane 1: original unfractionated serum; 
lane 2: molecular weight standard; lane 3: unbound protein fraction (see Data Supplements) and lane 4: IgY12 bound protein 
fraction. The same amount of total protein was loaded in each lane. Panel b-d: 2D electrophoresis gel of original unfractionated 
serum (panel b), IgY12 bound proteins (panel c), and Y12 unbound proteins (panel d). Each gel was load with 20 μg of proteins. 
Some protein spots (box 1 panel b), were present in both the original and the unbound fractions (panel d). Others (box 2, 
panel a-b) (albumin, haptoglobin.), where retained by the column and recovered in the bound fraction (panel c). Finally, 
unmasked by the fractionation, some "new" spots were detected only in the unbound fraction (box 3, figure b-d). These results 
were consistent with the work of Huang et al [18].
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Conclusion
Removal of the major serum proteins using an immuno-
capture method allows the SELDI-TOF detection of new
peaks, most likely corresponding to low abundant pro-
teins, in the unbound fractions. In the bound fractions,
major peaks were still detectable, as well as additional
peaks corresponding to proteins co-purified with the 12
proteins retained by the columns. Taken together, our
data showed that an approach combining immunocap-
ture of major serum proteins followed by SELDI-TOF is
reproducible, versatile, can be applied to a large number
of samples and we believe presents a major interest for
blood proteome analysis, profiling and biomarker discov-
ery.
Methods
Serum samples
Anonymized serum samples that had a normal pattern on
Hydragel (see below) were used for this study. Blood was
initially collected in Vacutainer tubes without additive, let
clot 30 minutes at room temperature and centrifuged for
30 min at 3000 × g. Serum was recovered and frozen at
minus 80°C until used.
IgY12 fractionation
Fractionation of serum proteins was performed as recom-
mended by the manufacturer (Beckmann, ref A24331).
Briefly, 10 μL of serum was mixed with 490 μL of Tris
buffer solution at pH 7.5 (TBS), added to IgY-microbead
spin column and incubated at room temperature for 15
min with rotation. The unbound proteins were collected
in a 2 mL eppendorf tube by centrifugation at 400 × g for
30 s. After 3 washes with TBS, bound proteins were eluted
in two steps with 500 μL of stripping buffer (0.1 M Gly-
cine, pH 2.5) and the fraction was then neutralised using
100 μL of 0.1 M TrisHCl pH 8. Concentration of the frac-
tion to 40 μL was then realized by PES ultrafiltration (see
below). Protein quantitation of the fractions demon-
strated that 86% (± 6.5%) of the initial proteins was
recovered with a distribution 84,3% (± 2.3%)/15.7% (±
2.3%) of bound/unbound proteins.
Hydragel analysis
For Hydragel separation and 2D electrophoresis, the
unbound and bound proteins were concentrated at 4°C
on PES ultrafiltration columns with a 10 kDa cutoff
(VIVASPIN 500, Vivascience ref VS0101) in 50 mM Tris
pH 8.8. The Hydragel technology from Sebia (ref: 4115)
allows the separation and the identification of major
serum proteins for clinical application. 5 μL of serum were
separated by electrophoresis on agarose following the kit
procedure. The proteins were stained by acidic coomassie
and the major protein identify by the banding pattern.
2D electrophoresis
After the spin columns, samples were mixed with in 200
μL of solubilizing buffer (8 M urea, 1 M thiourea, 4.8%
CHAPS, 50 mM DTT). Total protein quantitation was per-
Table 2: Summary of peak detection in the different fractions
Detected peaks Pearson Factor Between each replicate Number of unique peaks
Serum 32 ± 1 0.90 0
Bound compartment 29 ± 1 0.97 3
Unbound compartment 41 ± 0 0.95 24
Legend: Fractionation of serum samples (n = 4) by IgY12 spin columns and SELDI-TOF analysis. Peaks were detected using ProteinChip Software 
(Ciphergen Biosystems) between 3,000 to 15,000 m/z with a ratio signal/noise of 3. Pearson factor is calculated between replicates of each fraction. 
Note: unique peaks are those not present in any of the two other fractions.
Table 1: Repeatability and reproducibility of SELDI-TOF spectra before and after immunocapture.
Minimum CV value Maximum CV value
SELDI-TOF repeatability (p = 33) 9.7 25.9 15.7
SELDI-TOF reproducibility (p = 33) 8.7 52.1 22.2
Y12/SELDI-TOF repeatability (p = 31) 6.4 32.5 16.7
Y12/SELDI-TOF reproducibility (p = 30) 7.8 57.9 25.3
Legend: The coefficient of variation (CV) was calculated for the "p" peaks detected in the SELDI-TOF spectra using the ProteinChip Software 
(Ciphergen Biosystems). The minimum and maximum CV values are indicated on the table, as well as the mean CV values. For the SELDI-TOF and 
Y12/SELDI-TOF repeatability, a serum sample was analysed 8 times the same day; for the reproducibility, the same sera was analysed for 4 
consecutive days.
() / CV p 2 ∑Proteome Science 2006, 4:20 http://www.proteomesci.com/content/4/1/20
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formed using PlusOne 2-D Quant Kit (Amersham Bio-
sciences, ref 80-6483-56). For the first dimension, 20 μg
of the samples were diluted in 125 μL of rehydratation
buffer (9.8 M urea 4% CHAPS 50 mM DTT and 0.5% IPG
buffer 4–7). 7 cm IPG strips (Amersham ref 17-6001-10),
covering a pH range of 4 – 7 were rehydrated with this
solution during 18 h under low viscosity paraffin oil. For
focalisation, the following voltage/time profile was used
on a IPG Phor II: 300 V for 2 h, a gradient until 1000 V for
1 h, a gradient until 5000 V for 1 h 30 and 5000 V during
3 h 30. A total of 23250 vh was achieved. For the second
dimension, strips were equilibrated for 30 min in 6 M
urea, 30% glycerol, 2% SDS, 50 mM Tris pH
8.8,1%DTTand then incubated for an additional 30 min
in the same solution except that DTT was replaced by 5%
iodoacetamide. After equilibration, proteins were sepa-
rated in the second dimension in 4–12% NuPAGE gels
(Invitrogen). Gels were stained with a modified silver
nitrate procedure as in Shevchenko et al [19]. Gels were
scanned at 300 dots per inch using Labscan 3 software
after a procedure of calibration using kaleidoscope Laser-
Soft Imaging (Kodak, ref: R020123).
SELDI-TOF analysis before and after fractionation using IgY12 spin columns Figure 2
SELDI-TOF analysis before and after fractionation using IgY12 spin columns. SELDI-TOF spectrum (between 3,000 
and 15,000 m/z) of the original unfractionated serum (panel a), of the unbound (depleted) (panel b) and Y12 bound (panel c) 
protein fractions. Stars indicated peaks present only in one of the fraction. Panel d: hierarchical clustering using the peaks 
detected in the a to c panel (in duplicates) using the ProteinChip Software (Ciphergen Biosystems). Numbers on the top rep-
resent the m/z values of the peaks. Colors are related to relative distribution between the fractions; green: low level, red: high 
level, black average level. Triangles and stars indicated peaks that appeared specific of the unbound fraction or present in both 
bound and original fractions, respectively. Panel e: SEDLI-TOF spectra of pure IL-8 revealing a single peak with an apparent m/
z value of 8560. Serum spiked with 0.1 ng/μL of IL-8 was analysed before (panel f) or after (panel g) immunodepletion. A peak 
(triangle) aligned to that of the IL-8 was only readily detected after depletion in the unbound fraction. The additional peak in 
this fraction (triangle) corresponded, as in panel c, to an additional serum peak detected only after depletion.
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SELDI-TOF analysis
For SELDI-TOF analysis, the total unbound and bound
proteins obtained from 10 μl of serum were concentrated
to 40 μl by a 45 min centrifugation at 4°C on PES ultrafil-
tration columns with a 3 KDa cutoff (Millipore, ref
42403). 1 μl of the initial serum, 12 and 4 μl out of the 40
μl unbound and bound fractions were used for analysis.
These volumes have been chosen experimentally after
optimization. These samples were diluted 1.5 time with a
solution of 8 M Urea, 1% CHAPS and shaken 15 min at
room temperature. Denaturated samples were then mixed
with 100 μL of binding buffer (100 mM Ammonium Ace-
tate pH4, 0.1% Triton) for application on CM10 (weak
cation exchange) ProteinChip (Ciphergen, Fremont, CA).
CM10 ProteinChips arrays were pre-equilibrated with 150
μL of binding buffer using in 96 wells bioprocessor and
incubated 5 min with gentle agitation. After removing
binding buffers from the wells, denaturated samples were
added and incubated for 1 h on a plate shaker at room
temperature. The wells were washed two times with the
binding buffer and one time with 100 mM Ammonium
Acetate pH4 during 5 min, followed by a final brief rinse
with water. ProteinChip arrays were removed from the
bioprocessor and air-dried. Finally, 0.8 μL of saturated
sinapinic acid solution was applied twice to each spot and
the chips were allowed to air-dry again.
Mass spectrometric analysis was performed by SELDI-TOF
in a PBS-II ProteinChip reader (Ciphergen Biosystems)
using the same settings for all the samples and for data
collection (calibration, focusing mass, laser intensity and
detector sensitivity). Each spectrum was an average of at
least 100 laser shots. Externally calibration was done with
the All-in-1 Protein Standard II (Ciphergen Biosystems).
Spectra analysis was carried out using using the Protein-
Chip software version 3.2 (Ciphergen Biosystems). The
background was subtracted using the default software set-
tings. Peaks with a ratio signal/noise above 3 were identi-
fied by the ProteinChip Software. After normalization on
Total Ion Current (TIC) and quantification, the data were
exported to Hierarchical Clustering Explorer Software
(HCE v3 [20]). Clusters were processed using Pearson sta-
tistical test.
IL-8 spiking experiment
Human recombinant IL-8 (Calbiochem, ref 407673) was
aliquoted at 10 μg/mL in PBS and stored at -80°C. 2.5 μL
(25 ng) of this material was analysed by SELDI-TOF to
find the corresponding IL-8 peak. For the spiking experi-
ment, 0.1 ng of IL-8 was added per μl of serum (11.4 pM)
which was then analysed directly of after immunodeple-
tion as described above.
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